Skip to main content
OpenTrials
Completed

NCT Number: NCT04338087

The Effect of Assisted Reproductive Technology on Male Sexual Function.

Men participating in assisted reproductive technology treatments will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Erectile Dysfunction Genital Diseases Genital Diseases, Male Male Urogenital Diseases Mental Disorders Sexual Dysfunction, Physiological Sexual Dysfunctions, Psychological Urogenital Diseases

Age range

18 year–60 year

Sex eligibility

Male

Study type

Observational

Primary location

Rambam healthcare campus

Haifa, Israel

About this study

Men participating in fertility will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth. In addition, participants will be questioned regarding marital life, sexual intercourse frequency, medical history and treatments for erectile dysfunction in relevant cases. Thes control group will be comprised of male subjects who did not require fertility treatments to conceive.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participation in fertility treatments.

Exclusion criteria

  • None.

Treatment and study plan

Questionnaire and personal interviews.

Other

Questionnaire and personal interviews.

Primary outcomes

  1. Changes in International index of erectile function score

    Time frame: From recruitment up to 3 years.

    Changes in International index of erectile function score with a possible score ranging from 0 to 75. The higher the score, the better erectile function is.

Secondary outcomes

  1. Sexual intercourse rate.

    Time frame: From recruitment up to 3 years.

    Sexual intercourse rate as measured by the average monthly intercourse rate.

  2. Use of phospho-di-esterase 5 inhibitors

    Time frame: From recruitment up to 3 years.

    Use of phospho-di-esterase 5 inhibitors as measured by the number of men using this medication.

Sponsors and collaborators

Lead sponsor

Rambam Health Care Campus

Other

Registry information

Official study title

The Correlation Between Assisted Reproductive Technology and Male Erectile Dysfunction.

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Apr 8, 2020
Registry last updated
Apr 8, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.